These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 1630814

  • 1. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.
    Ruggeri B, Zhang SY, Caamano J, DiRado M, Flynn SD, Klein-Szanto AJ.
    Oncogene; 1992 Aug; 7(8):1503-11. PubMed ID: 1630814
    [Abstract] [Full Text] [Related]

  • 2. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA.
    Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
    [Abstract] [Full Text] [Related]

  • 3. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
    Ruggeri B, Caamano J, Goodrow T, DiRado M, Bianchi A, Trono D, Conti CJ, Klein-Szanto AJ.
    Cancer Res; 1991 Dec 15; 51(24):6615-21. PubMed ID: 1742735
    [Abstract] [Full Text] [Related]

  • 4. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
    Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, McDaniel T, Boynton RF, Zou ZQ.
    Cancer Res; 1993 Apr 15; 53(8):1889-94. PubMed ID: 8467510
    [Abstract] [Full Text] [Related]

  • 5. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines.
    Kim MS, Li SL, Bertolami CN, Cherrick HM, Park NH.
    Anticancer Res; 1993 Apr 15; 13(5A):1405-13. PubMed ID: 8239512
    [Abstract] [Full Text] [Related]

  • 6. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y, Hayashi K, Hirohashi S, Sekiya T.
    Cancer Res; 1991 Oct 15; 51(20):5520-5. PubMed ID: 1655254
    [Abstract] [Full Text] [Related]

  • 7. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM.
    Cancer Res; 1993 Jul 01; 53(13):3092-7. PubMed ID: 8319216
    [Abstract] [Full Text] [Related]

  • 8. p53 and K-RAS alterations in pancreatic epithelial cell lesions.
    Kalthoff H, Schmiegel W, Roeder C, Kasche D, Schmidt A, Lauer G, Thiele HG, Honold G, Pantel K, Riethmüller G.
    Oncogene; 1993 Feb 01; 8(2):289-98. PubMed ID: 8426738
    [Abstract] [Full Text] [Related]

  • 9. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ, Ozbun MA, Kittrell FS, Lane DP, Medina D, Butel JS.
    Cancer Res; 1993 Jul 15; 53(14):3374-81. PubMed ID: 8324748
    [Abstract] [Full Text] [Related]

  • 10. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.
    Cancer; 1997 Feb 15; 79(4):700-16. PubMed ID: 9024708
    [Abstract] [Full Text] [Related]

  • 11. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L, Goodrow TL, Zhang SY, Klein-Szanto AJ, Chang H, Ruggeri BA.
    Cancer Res; 1996 Mar 01; 56(5):1137-41. PubMed ID: 8640773
    [Abstract] [Full Text] [Related]

  • 12. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.
    Cote RJ, Jhanwar SC, Novick S, Pellicer A.
    Cancer Res; 1991 Oct 01; 51(19):5410-6. PubMed ID: 1913660
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y, Hayashi H, Kawai K, Kurakane T, Saitoh Y, Kitamura S, Sengoku K, Ishikawa M.
    Exp Cell Res; 1997 Jun 15; 233(2):233-9. PubMed ID: 9194486
    [Abstract] [Full Text] [Related]

  • 14. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
    Stratton MR, Moss S, Warren W, Patterson H, Clark J, Fisher C, Fletcher CD, Ball A, Thomas M, Gusterson BA.
    Oncogene; 1990 Sep 15; 5(9):1297-301. PubMed ID: 2216456
    [Abstract] [Full Text] [Related]

  • 15. [Epidermoid carcinoma of the cervix uteri: molecular abnormalities of p53 and rb genes].
    Wistuba I, Capurro I.
    Rev Med Chil; 1996 May 15; 124(5):553-60. PubMed ID: 9035506
    [Abstract] [Full Text] [Related]

  • 16. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
    Ishikawa J, Xu HJ, Hu SX, Yandell DW, Maeda S, Kamidono S, Benedict WF, Takahashi R.
    Cancer Res; 1991 Oct 15; 51(20):5736-43. PubMed ID: 1913692
    [Abstract] [Full Text] [Related]

  • 17. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.
    Reiss M, Brash DE, Muñoz-Antonia T, Simon JA, Ziegler A, Vellucci VF, Zhou ZL.
    Oncol Res; 1992 Oct 15; 4(8-9):349-57. PubMed ID: 1486218
    [Abstract] [Full Text] [Related]

  • 18. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines.
    Hosono S, Lee CS, Chou MJ, Yang CS, Shih CH.
    Oncogene; 1991 Feb 15; 6(2):237-43. PubMed ID: 1847999
    [Abstract] [Full Text] [Related]

  • 19. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.
    Yaginuma Y, Westphal H.
    Cancer Res; 1992 Aug 01; 52(15):4196-9. PubMed ID: 1638534
    [Abstract] [Full Text] [Related]

  • 20. Establishment and characterization of four human pancreatic carcinoma cell lines. Genetic alterations in the TGFBR2 gene but not in the MADH4 gene.
    Ku JL, Yoon KA, Kim WH, Jang Y, Suh KS, Kim SW, Park YH, Park JG.
    Cell Tissue Res; 2002 May 01; 308(2):205-14. PubMed ID: 12037578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.